Fortune 500 pharmaceutical company

January 1, 2015

Representation of a Fortune 500 pharmaceutical company in connection with the registration of billion dollar medium term note program. Also represented them in a number of takedowns from its shelf, including the sale of $450,000,000 of notes.
Back to top